chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Severe pain in upper neck, left shoulder, left arm; Severe pain in upper neck, left shoulder, left arm; Severe pain in upper neck, left shoulder, left arm; pain to left shoulder and left arm where the shot was given/Severe muscle pain on injection arm; Left wrist ache; was not sleeping; severe muscle pain; This is a spontaneous report from a contactable consumer or other non hcp. A 61-years-old female patient received bnt162b2 (BNT162B2), dose 2 via an unspecified route of administration, administered in Arm Left on 03May2021 10:00 (Batch/Lot Number: EN6208) as 2ND DOSE, SINGLE for covid-19 immunisation. Medical history included nerve injury from an unknown date and unknown if ongoing, intervertebral disc operation from 2019 to an unknown date, nuchal rigidity (Can't turn neck to the left past a certain point) from an unknown date and was ongoing. The patient's concomitant medications were not reported. The patient previously took first dose of bnt162b2m (Lot number: EN6198) on 12Apr2021 (at the age of 61-year-old) for covid-19 immunisation; the past drug includes naproxen which worked well. The patient developed pain to left shoulder and left arm where the shot was given a week later/ Severe muscle pain on injection arm, on an unknown date in May2021, severe pain in upper neck, left shoulder, left arm on 07May2021, experienced left wrist ache, was not sleeping on an unknown date in May2021. It was reported that patient used ice packs on it and taking Naproxen around the clock, but nothing touches it. Starts to feel like she was getting better, but really was not. The patient had no cold or flu symptoms. It was reported that patient visited chiropractor on 01May2021 for this crick in her neck. States she did not have COVID arm and did not have redness or swelling on the injection arm. It was also reported that patient had severe muscle pain on an unknown date in May2021. The patient has been taking Naproxen (Kroger brand, Formulation: 220mg caplets, NDC: 30142-617-90, Lot: 9ER0418, Exp: Dec2020) at a dose of three caplets in the morning. A couple of nights did two caplets 12-14 hours later; Lidocaine Patches (NDC: 0603188010; Lot: 74098; Exp: Jun2017; Formulation: 5%, 700mg patches) at a dose of patch on last night where the main part of the pain was at, which was the injection site, put one patch on the left arm and one patch on the upper part of the left shoulder near her back, left patches on overnight, about six hours. The outcome of the events pain to left shoulder and left arm where the shot was given/Severe muscle pain on injection arm, Severe pain in upper neck, left shoulder, left arm was not resolved, left wrist ache was resolved on May2021 and was not sleeping, severe muscle pain was unknown.  No follow-up attempts are needed. No further information is expected
Pt developed dizziness, sob, and anxiety. Symptoms likely r/t anxiety. BP 160/78, HR 77, SpO2 98% RA. Repeat BP 119/70. Pt reported feeling better but still slightly dizzy from the inhaler, which is common for her.
Throbbing all night; nausea; severe pain; redness down arm from shoulder to elbow.
Began with slower response to questions and reaction to events.  By Feb 10, was having hallucinations, hearing things that weren't there, fear, etc.  Hospitalized Feb 12 when he could no longer respond or figure out what was reality and what wasn't.  Within days, the doctor did not know if he would live or die.  He couldn't eat, slept alot, etc.  They new it was a virus in his brain, but not what kind.
Swelling of face; tightness in chest and shortness of breath and difficulty talking (with the exception of the swelling of the face, these are typical of my reactive airway) Treatment: Benedryl, albuteral,  Outcome: Swelling has gone down, breathing is somewhat better
she is confused; This is a spontaneous report received from a contactable reporter (Consumer or other non HCP) for a sponsored program (159558). The reporter is the patient.  A female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), administration date 12Mar2021 (Batch/Lot number: unknown) as dose 1, single for COVID-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: CONFUSIONAL STATE (non-serious), outcome "unknown", described as "she is confused".  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Tingling/parathesis and a feeling of "crawling" within his right ear and near his temporal area. He also notices electrical impulses near his nostrils and eyes.
SWELLING AND REDNESS AND PAIN LASTING 6 WEEKS POST 3RD DOSE OF GARDASIL GIVEN ON LEFT DELTOID, IM
Symptoms include SOB.        Patient denies loss of taste, loss of smell.        Pertinent medical history includes asthma.        Exposures reported: positive.  Patient continues to have cough, low energy, body aches, shortness of breath. Symptoms are not worse from a couple days ago but certainly persisting. starting 11/30/21
This case was reported by a other health professional via call center representative and described the occurrence of pain in a 76-year-old male patient who received SHINGRIX (batch number 4FS5N, expiry date 8th March 2021) for prophylaxis. On 20th September 2018, the patient received SHINGRIX (intramuscular) .5 ml. On 21st September 2018, 1 days after receiving SHINGRIX, the patient experienced pain and erythema. On an unknown date, the outcome of the pain and erythema were recovering/resolving. It was unknown if the reporter considered the pain and erythema to be related to SHINGRIX. Additional details were provided as follows: This case was reported by the Certified pharmacy technician (Cpht). The patient received SHINGRIX in right arm. The patient was extremely upset with the pharmacy and said that the vaccine was hurting him really bad on Friday. The symptoms got worse on Saturday and Sunday and it was somewhat better on Monday (date of reporting), but the patient said that it was still hurting him. The reporter said that the patient hung up on them and could not confirm the symptoms. The patient mentioned redness and being painful, but reporter did not know exactly where the events were located.
This spontaneous report as received from a nurse practitioner via company representative refers to a 71 year old female patient. On 24-NOV-2014, the patient was vaccinated with a dose of PNEUMOVAX 23 lot # K009876, expiration date reported as 19-MAR-2016 (dose, dose number and route of vaccination were not reported) for prevention of pneumonia. It was reported that after receiving a PNEUMOVAX 23 vaccine, the patient presented at the clinic with injection site redness and surrounding area feeling "hot" and the patient was diagnosed with cellulitis (onset date reported as 25-NOV-2014). The event was treated with an unspecified antibiotics. The outcome of the event was unknown. The patient sought medical attention by visiting the clinic. The relatedness between the event and PNEUMOVAX 23 was not reported. Additional information has been requested.
Information has been received on 01/30/2001 from a published literature article regarding a 14 year old male. In 1997, two years after receiving his sixth dose of DTP (manufacturer unknown), he was hospitalized with a diagnosis of tetanus. The reporter indicated that the child received a puncture wound from small dog bite on the lower calf. Treatment included tetanus immune globulin administered 7-23hours post onset of symptoms. He was discharged after 3 days.
an adult patient was vaccinated with a pediatric dose of RECOMBIVAX; no adverse symptoms reported; This spontaneous report was received from a pharmacy intern and refers to an adult patient of unknown age and gender. Information about the patient's medical history, concurrent conditions, concomitant medications and drug reactions or allergies was not provided.      On an unknown date, the patient was vaccinated with a pediatric dose of hepatitis b vaccine (recombinant)(RECOMBIVAX HB) for prophylaxis (strength, dose, frequency, route, lot number and expiration date were not provided). No adverse symptoms were reported.
shingles; Information has been received from a lawyer and a patient of unknown age and gender regarding a case in litigation. Information about concurrent condition, medical history and concomitant medication was not reported. In 2016, the patient was vaccinated with zoster vaccine live (ZOSTAVAX) (strength, dose, lot# and route unknown) for the long-term prevention of shingles and zoster-related conditions. Subsequent to the inoculation (date not reported), the patient was treated by a physician for shingles. As a direct and proximate result of zoster vaccine live (ZOSTAVAX), the patient has and will continue suffer ongoing injuries, including but not limited to: mental and physical pain and suffering; medical care and treatment for these injuries; significant medical and related expenses as a result of these injuries, including but not limited to medical losses and costs include care for hospitalization, physician care, monitoring, treatment, medications, and supplies; diminished capacity for the enjoyment of life; diminished quality of life; increased risk of premature death, aggravation of preexisting conditions and activation of latent conditions; and other losses and damages; and will continue to suffer such losses, and damages in the future. The outcome of the event shingles was not recovered. The causality assessment was considered as related by the lawyer.
Information has been received from a registered nurse concerning an 8 year old male who was vaccinated with a dose of varicella virus vaccine live.  Subsequently the patient developed mild breakthrough varicella. It is unknown if medical attention was sought. The patient's outcome was unknown. There was no product quality complaint involved. Additional information has been requested.
got the flu; Initial information received from on 05-Jan-2022 regarding an unsolicited valid Social Media non-serious case received from a consumer/non-hcp (non health care professional).  This case involves Adult and unknown gender patient who experienced got the flu while receiving vaccine INFLUENZA VACCINE.  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.  In 1975, the patient received a  dose of suspect INFLUENZA VACCINE produced by unknown manufacturer lot number not reported via unknown route in unknown administration site for Prophylactic vaccination.  On an unknown date the patient developed a non-serious got the flu (influenza) (unknown latency) following the administration of INFLUENZA VACCINE.  Action taken with INFLUENZA VACCINE (INFLUENZA VACCINE) was not applicable.  It was not reported if the patient received a corrective treatment for the event (got the flu).  At time of reporting, the outcome was Unknown for the event got the flu.
Pt vaccinated with DTP/HIB/OPV developed lt swollen & indurated & tender thigh. No redness. X-ray negative. Treated w/warm soaks & Tylenol & Benedryl.
Patient has bumps/small lumps on both legs. They are light purple, but fades away sometimes. Does not increase in size. Patient complains in pain when touched.
Laryngismus. A duplicate report is in system: U1999-00797. This report is the original. It was reported that a 38-year-old female received vaxs on 09/30/99. Reportedly 2 hours post vax, the pt felt as though her throat was closing. She reported was seen in the office and was treated with steroids. Information received states that 5 hours post vax, this pt experienced a 'hoarse voice, swelling of the throat and coughing. Pt was given Solu-Medrol 125mg and breathing treatment of Albuterol and Atrovent.' She also  experienced chest tightness. The pt recovered completely.
This spontaneous case was reported by a patient and describes the occurrence of INFLUENZA LIKE ILLNESS (got a pretty bad dose of flu), NASOPHARYNGITIS (cold), FEELING ABNORMAL (miserable/felt really crummy/with one of the boosters I felt crummy for a month), MALAISE (I've been feeling lousy the last couple of days too) and ABNORMAL BEHAVIOUR (I didn't know if I was sleeping or hallucinating/unsavory dreams so he thinks he may have been hallucinating/very vivid, unsavory dreams/didn't know if I was dreaming or hallucinating/you pass through these different stages) in a 73-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 002M21A, 014F21A, 041B21A and 046A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below. Concurrent medical conditions included Gluten intolerance, Lactose intolerance, Food allergy, Babesia, Arrhythmia and Lyme disease. Concomitant products included NEBIVOLOL HYDROCHLORIDE (BYSTOLIC) and FLECAINIDE ACETATE for Arrhythmia, ARTEMISININ for Babesia, MAGNESIUM, FINASTERIDE, COLECALCIFEROL (VITAMIN D3), CRYPTOLEPIS DUBIA and CAT'S CLAW [UNCARIA TOMENTOSA] for an unknown indication. On 19-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .5 milliliter. On 16-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to .5 milliliter. On 27-Oct-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to .25 milliliter. On 01-Apr-2022, received fourth dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to .25 milliliter. On an unknown date, the patient experienced INFLUENZA LIKE ILLNESS (got a pretty bad dose of flu), NASOPHARYNGITIS (cold), FEELING ABNORMAL (miserable/felt really crummy/with one of the boosters I felt crummy for a month), MALAISE (I've been feeling lousy the last couple of days too), ABNORMAL BEHAVIOUR (I didn't know if I was sleeping or hallucinating/unsavory dreams so he thinks he may have been hallucinating/very vivid, unsavory dreams/didn't know if I was dreaming or hallucinating/you pass through these different stages), HEADACHE (headache) and CHILLS (chills). At the time of the report, INFLUENZA LIKE ILLNESS (got a pretty bad dose of flu), NASOPHARYNGITIS (cold), FEELING ABNORMAL (miserable/felt really crummy/with one of the boosters I felt crummy for a month), MALAISE (I've been feeling lousy the last couple of days too), ABNORMAL BEHAVIOUR (I didn't know if I was sleeping or hallucinating/unsavory dreams so he thinks he may have been hallucinating/very vivid, unsavory dreams/didn't know if I was dreaming or hallucinating/you pass through these different stages), HEADACHE (headache) and CHILLS (chills) had resolved. No treatment medication was reported. This case was linked to MOD-2022-633815, MOD-2022-633816 (Patient Link).
Patient had an appointment for her first Covid vaccination today at 10:30am. Pt came in feeling fine but anxious about getting her vaccination. Pt also mentioned to both intern and I that she is a hypochondriac. She got her IM vaccination and sat down for 15 minutes as we monitored her. After her 15 minutes of sitting down in pharmacy area and being monitored by our intern and pharmacist, they asked how she's doing. Pt expressed she felt fine but had a dry mouth, and the intern told her to call 911 immediately if any shortness of breath occurred, but patient felt fine and left. About 25 minutes later she returned and expressed that she had a metallic taste in her mouth and was anxious about the shot. We asked her to sit down so we can monitor her further and she did. Five minutes later she expressed tongue swollen a little and a little difficulty swallowing but had no trouble breathing. At that time pharmacy intern and I (pharmacist) decided to give the epipen injection and patient agreed. We had the patient sit down for another 30 minutes as we monitored her. Minutes later, pt started to feel better as we continuously monitored her. During this time patient requested water due to dry mouth. We handed her a bottle of water but asked her to please sip and not take big gulps. After 30 minutes patient felt better. No swollen tongue, no difficulty swallowing or breathing and anxiety had been relieved. Patient was notified by pharmacy to call MD to let him know of reaction and was also told to call 911 immediately if have any further reaction. PT felt comfortable to leave at this point.
My left eye began twitching about 2 hours after the vaccination and continued on and off for two days. This has never happened to me and was very bizarre.   I couldn?t think clearly for around two days, especially the first day, and my hand dexterity was very poor on the first day.  I couldn?t type well or do normal motor functions on the phone or computer.  I was also extremely tired for around 1 day could barely keep my eyes open, starting a few hours after the vaccine.  I also had moderate pain in my lower right stomach although that has largely subsided after 4 days.  I had moderate pain in my arm that went away after 2-3 days.    I also had intermittent chest pain.  I never recall having any reactions to any vaccines before other than pain in the arm.  This was very very different.  If I had known I would have this reaction, especially with whatever was happening with my brain and chest, I definitely would not have received the vaccine.
had my first dose of moderna today and im 17; This spontaneous case was reported by a consumer and describes the occurrence of PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (had my first dose of moderna today and im 17) in a 17-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. unknown) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (had my first dose of moderna today and im 17). At the time of the report, PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (had my first dose of moderna today and im 17) had resolved.            No concomitant medication reported. No treatment medication reported.
07/28/2022 in the morning  I had  cough and  I was feeling weak so, I decided to test for COVID-19. I was positive.  I did a tele health with my doctor the same day  who prescribed me with Paxlovid for 5 days. It took me 3 days to get better.
Systemic: Flushed / Sweating-Mild, Systemic: Shakiness-Mild, Additional Details: Patient has been fasting and did not mention to immunizer that she passed out twice today because she is not eating anything only water. Paramedics came and check on her and patient was stable and recovered at the time.
Woke up the following day with a massive headache. Whole body and joints were sore. Unable to get comfortable doing anything. Some troubles/labored breathing for 1 day.
Redness, swelling, hard, hot to touch for a 6in x 10in area on left thigh.
This spontaneous report as received from a medical assistant refers to unspecified number of patients of unknown age. Multiple patients were vaccinated with GARDASIL (dose, lot no. unknown). No concomitant medication was reported. The medical assistant reported that multiple patients have received GARDASIL off schedule. Medical assistant reported that there were multiple patients who get their first dose and wait for a year or longer to get their second dose. No adverse effect was reported. The outcome of events was unknown. Product quality complaint was not reported. Additional information is not expected.
After a 3 shots, got itchy bumps on legs. After 5th shot, got itchy bumps on arms. After 6th/last shot got itchy bumps on hands. Went to dermatologist, am now illergic to Quanterium 15 and Polyquanteriums... found in lotions, baby products, cleaning products, shampoos, etc... Was not Allergic to any of these items before.have been given flucinonide for topical treatement and if that doesn't work, oral steroid pills. Can no longer work in Kitchen, which was my primary job. Have an infant and cannot give him a bath or use wipes without gloves. Cannot use most products listed above.
Developed tender, hard area, with slight redness 2" below injection site.  About 6 days later (14 days after injection) a bright red, raised, itchy rash that felt ?tight? and very warm to touch, covered back of upper left arm (6" in length), wrapping around to front of upper arm below injection site (5? total width in some areas).  Applied aloe gel with Lidocaine .5% to affected area.  3-4 days after large rash began, two (2) new  affected areas along perimeter of existing rash and around injection site developed.  Within 5 days (21 days after injection) rash was healed with a slight redness remaining in the most recently affected perimeters.
This spontaneous report was received from a healthcare professional who reported that in January 2014, 21 improperly stored doses of ROTATEQ, (oral, dose, batch and lot number not reported) were administered by a clinic to an unspecified number of patients (age and gender were not reported). No adverse effects were reported. This is one of several reports from the same source. Follow up information has been received on 17-MAR-2014. All telephone attempts to obtain follow-up information had been unsuccessful. Follow up information has been received on 22-SEP-2014. Demographic details for each patient were provided. This report referred to an 6-months old patient of unknown gender, with no known drug allergies. As illness at time of vaccination, it was reported that the patient had mild stuffy nose. The patient was vaccinated with the third dose of ROTATEQ (oral, batch/lot # J001254, expiration date 19-SEP-2014), on 12-FEB-2014 at 11:50 AM. It was reported that this dose was spoiled since the refrigerator was too cold (onset of event was also reported as 27-FEB-2014 at 10:00 AM). The parents of the patient were going to consult with physician to repeat the dose at no charge. No adverse event was reported for the patient. Outcome was reported by the reporter as recovered. This is one of several reports from the same source. Additional information is not expected since all follow ups requested to complete the case were received.
Cough; fatigue; deep pain in bones and joint; didn't sleep well; diarrhea; fever. All symptoms last 5 day except the cough.
Got rash on both the doses of SHINGRIX shots. More on 2nd dose. She took BENADRYL.
headache; This is a spontaneous report from a contactable consumer or other non healthcare professional.This is a spontaneous report from a Pfizer sponsored program. A contactable consumer (patient's father) reported for a 18-year-old female patient (reporter's daughter) that: A 18 year old female patient received bnt162b2 (BNT162B2), dose 1 via an unspecified route of administration on 16Aug2021 (Batch/Lot number was not reported) as DOSE 1, SINGLE for covid-19 immunisation..The patient medical history and concomitant medications were not reported. The patient experienced headache on 17Aug2021 with outcome of unknown. The patient underwent lab tests and procedures which included sars-cov-2 test:with unknown results.   The lot number for the vaccine BNT162B2 was not provided and will be requested during follow up.
Started having chills & shaking, then dropped to floor with chills & shaking, 1 min post/vax. Rash on abdomen, noted by RN in ER. Temp up to 100F. Tx'd with IV Benadryl & Epinephrine. Sent home after 1 hr w/Benadryl po.
Patient was diagnosed with Guillain Barre syndrome 2/15/22 at Hospital and was told likely due to shingles vaccine received in January. Patient received IVIG treatment and upon improvement was discharged to rehab facility on 2/23/22. Completed approximately 30 days of rehab and was discharged able to walk again.
Temperature increasing up to 103 degrees.  Ibuprofen & Tylenol every 4 hours.  Make child comfortable, keep her cool.
Pt recv vax on 10/26/98; 1 hr post vax pt exp lump at vax site/ erythemic, warm area/ sore x 1 wk